PROCEPT BioRobotics Corporation Common Stock (PRCT) Stock Price

PRCTStock

$17.57−48.23%52W

Market Cap$1.01B

P/E—

PEG Ratio—

Div yield—

Beta0.88

PRCT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-38.45%

Price vs S&P 500 (4W)-3.75%

VGM Score57.49

Book Value / Share (Quarterly)$5.94

P/TBV (Annual)4.81x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)60.14%

Cash Flow / Share (Quarterly)$-1.48

Price vs S&P 500 (YTD)-56.08%

Gross Margin (TTM)64.22%

Net Profit Margin (TTM)-32.54%

EPS (TTM)$-1.95

10-Day Avg Trading Volume1.34M

EPS Excl Extra (TTM)$-1.95

Revenue Growth (5Y)109.03%

EPS (Annual)$-1.72

ROI (Annual)-22.89%

Gross Margin (Annual)63.70%

Net Profit Margin (5Y Avg)-87.86%

Cash / Share (Quarterly)$3.98

Revenue Growth QoQ (YoY)19.34%

ROA (Last FY)-18.81%

Revenue Growth TTM (YoY)22.69%

EBITD / Share (TTM)$-1.90

ROE (5Y Avg)-30.64%

Operating Margin (TTM)-33.86%

Cash Flow / Share (Annual)$-1.04

P/B Ratio2.96x

P/B Ratio (Quarterly)3.78x

Net Income / Employee (Annual)$-107,600

EV / Revenue (TTM)2.46x

Net Interest Coverage (TTM)-26.49x

ROA (TTM)-22.11%

EPS Incl Extra (Annual)$-1.72

Current Ratio (Annual)6.85x

Quick Ratio (Quarterly)5.23x

3-Month Avg Trading Volume1.54M

52-Week Price Return-48.23%

Revenue / Employee (TTM)$379,900

Tangible BV / Share (Quarterly)$5.93

P/S Ratio (Annual)3.27x

Asset Turnover (Annual)0.61x

52-Week High$38.11

Operating Margin (5Y Avg)-85.20%

EPS Excl Extra (Annual)$-1.72

CapEx CAGR (5Y)109.83%

26-Week Price Return-28.55%

Quick Ratio (Annual)5.62x

13-Week Price Return-8.58%

Total Debt / Equity (Annual)0.14x

Current Ratio (Quarterly)6.55x

Enterprise Value$830.10M

Revenue / Share Growth (5Y)97.92%

Asset Turnover (TTM)0.68x

Revenue / Employee (Annual)$346,900

Inventory Turnover (Annual)1.76x

Pretax Margin (Annual)-30.96%

Cash / Share (Annual)$5.09

3-Month Return Std Dev58.85%

Gross Margin (5Y Avg)54.49%

Net Income / Employee (TTM)$-123,600

ROE (Last FY)-26.12%

Net Interest Coverage (Annual)-35.41x

EPS Basic Excl Extra (Annual)$-1.72

Receivables Turnover (TTM)3.58x

Total Debt / Equity (Quarterly)0.15x

EPS Incl Extra (TTM)$-1.95

Receivables Turnover (Annual)3.69x

ROI (TTM)-26.76%

P/S Ratio (TTM)2.98x

Pretax Margin (5Y Avg)-87.85%

Revenue / Share (Annual)$5.55

Tangible BV / Share (Annual)$6.48

Price vs S&P 500 (52W)-63.76%

Year-to-Date Return-44.15%

5-Day Price Return-10.22%

EPS Normalized (Annual)$-1.72

ROA (5Y Avg)-21.61%

Net Profit Margin (Annual)-31.02%

Month-to-Date Return-3.57%

Cash Flow / Share (TTM)$-2.26

EBITD / Share (Annual)$-1.75

Operating Margin (Annual)-33.71%

LT Debt / Equity (Annual)0.14x

ROI (5Y Avg)-25.78%

LT Debt / Equity (Quarterly)0.15x

EPS Basic Excl Extra (TTM)$-1.95

P/TBV (Quarterly)3.79x

P/B Ratio (Annual)4.80x

Inventory Turnover (TTM)1.68x

Pretax Margin (TTM)-32.46%

Book Value / Share (Annual)$6.50

Price vs S&P 500 (13W)-11.27%

Beta0.88x

Revenue / Share (TTM)$5.91

ROE (TTM)-30.62%

52-Week Low$16.66

vGradeC

gGradeA

mGradeD

vgmGradeC

PRCT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 4, 2026	-$0.45	-$0.47	-3.69%(-$0.02)
Q1 2026	Apr 29, 2026	-$0.56	-$0.56	+0.88%(+$0.01)
Q4 2025	Feb 25, 2026	-$0.32	-$0.53	-64.10%(-$0.21)
Q3 2025	Nov 4, 2025	-$0.42	-$0.38	+9.76%(+$0.04)
Q2 2025	Aug 6, 2025	-$0.41	-$0.35	+14.63%(+$0.06)

PRCT Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.90

3.82

3.71

3.57

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About PROCEPT BioRobotics Corporation Common Stock

PROCEPT BioRobotics develops, manufactures, and sells image-guided robotic surgical systems for minimally invasive urologic procedures. The company's AquaBeam and HYDROS platforms primarily address the benign prostatic hyperplasia market, with revenue concentrated in the United States and expanding international operations.

PRCT Next Earnings Report

Report dateNov 4, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.39

Revenue estimate$100.71M

Also reporting on Nov 4, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

PRCT Insider Transactions

SellSep 9, 2026
WATERS KEVIN
Chief Financial Officer
Shares: 373Value: $7,815
SellSep 9, 2026
TEMPLIN BARRY L
Chief Technology Officer
Shares: 373Value: $7,815
SellSep 9, 2026
NOURI ALALEH
Officer
Shares: 297Value: $6,223
BuyAug 7, 2026
WOOD LARRY L
Chief Executive Officer
Shares: 23,900Value: $498,315

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

LYNXLyntris Inc.Defense Systems & Equipment
ENOVEnovis CorporationOrthopedic & Prosthetic Devices
CDRECadre Holdings, Inc.Orthopedic & Prosthetic Devices
STAAStaar Surgical CoOphthalmic Goods
CBLLCeriBell, Inc. Common StockElectromedical Equipment
KODKEASTMAN KODAK COMPANYPhotographic Equipment & Supplies
INMDInMode Ltd. Ordinary SharesElectromedical Equipment
TRNSTranscat IncInstruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

3.6

Buy

Consensus rating

52-Week Range

Low$16.66

High$38.11